GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO.NS
2561.15 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||||
| Net Income
| 5,899.61 | 8,415 | 24,756.481 | 7,230.952 | 6,472.462 | 6,539.702 | 5,221.667 | 4,654.554 | 5,768.557 | 3,811.287 | 6,852.96 | 9,825.782 | 9,273.318 | 8,716.156 | 7,611.645 | 7,010.107 | 6,275.29 | 5,663.372 | 4,884.27 | 4,278.91 |
| Depreciation & Amortization
| 695.358 | 657.7 | 681.86 | 792.836 | 826.777 | 485.907 | 379.858 | 263.469 | 247.765 | 202.82 | 198.814 | 178.393 | 204.078 | 176.282 | 163.686 | 163.365 | 205.368 | 200.763 | 199.831 | 217.242 |
| Deferred Income Tax
| 0 | -25.334 | -65.448 | -128.506 | -132.117 | -77.456 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 113.97 | 25.334 | 65.448 | 128.506 | 132.117 | 77.456 | 73.504 | 57.266 | 87.971 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 610.207 | -457.4 | 1,198.718 | 457.601 | 440.682 | -41.926 | 1,645.58 | -257.89 | -1,236.33 | -474.434 | 114.455 | 517.322 | -728.201 | 126.567 | 204.7 | -325.748 | 72.307 | -403.31 | 437.985 | 124.474 |
| Accounts Receivables
| -302.689 | 202.283 | 102.04 | -999.342 | -0.497 | 268.919 | 231.603 | -442.317 | -262.471 | -31.398 | 195.048 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -650.778 | 747.2 | 120.027 | -467.93 | -677.167 | 136.898 | -743.859 | 1,000.692 | -1,502.839 | -228.902 | -618.249 | 473.318 | -507.296 | -282.569 | -243.212 | -217.691 | 161.371 | -345.203 | 80.761 | -5.411 |
| Accounts Payables
| 1,901.367 | -1,532.15 | 1,023.749 | 1,074.097 | -482.297 | -1,000.405 | 2,269.279 | -467.806 | 197.025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -337.693 | 125.267 | -47.098 | 850.776 | 1,600.643 | 552.662 | 2,389.439 | -1,258.582 | 266.509 | -214.135 | 732.704 | 44.004 | -220.905 | 409.136 | 447.912 | -108.057 | -89.064 | -58.107 | 357.224 | 129.885 |
| Other Non Cash Items
| -10.121 | -3,773 | -18,529.581 | -2,702.135 | -2,834.924 | -2,989.902 | -2,519.139 | -2,300.169 | -3,388.085 | -838.526 | -4,353.087 | -7,385.571 | -5,392.802 | -4,225.372 | -2,864.865 | -3,547.421 | -3,364.618 | -2,874.884 | -2,028.265 | -2,330.414 |
| Operating Cash Flow
| 6,752.238 | 4,842.3 | 8,107.478 | 5,779.254 | 4,904.997 | 3,993.781 | 4,727.966 | 2,359.964 | 1,391.907 | 2,701.147 | 2,813.142 | 3,135.926 | 3,356.393 | 4,793.633 | 5,115.166 | 3,300.303 | 3,188.347 | 2,585.941 | 3,493.821 | 2,290.212 |
| Investing Activities: | ||||||||||||||||||||
| Investments In Property Plant And Equipment
| -312.215 | -440.4 | -346.41 | -442.266 | -1,558.981 | -2,912.814 | -4,033.841 | -3,044.291 | -2,323.203 | -1,304.982 | -582.217 | -390.763 | -420.951 | -213.944 | -303.666 | -238.787 | -153.258 | -186.232 | -233.914 | -93.72 |
| Acquisitions Net
| 44.69 | 1,942.1 | 335.196 | 1,800 | 1,558.981 | 2,912.814 | 4,033.841 | 1,318.536 | 241.252 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,500 | 2,071 | -100 | 0 |
| Purchases Of Investments
| -58,022.332 | -52,642.9 | -30,693.751 | -33,782.3 | -11,410 | -12,410 | -10,690 | -7,865 | -19,930 | 0 | -21,497.5 | -22,197.5 | 0 | 0 | 0 | -221.761 | -2,092.059 | -2,321.887 | -1,515.4 | -2,842.419 |
| Sales Maturities Of Investments
| 56,787.827 | 62,205.8 | 12,570 | 36,032.3 | 12,330 | 12,610 | 7,365 | 12,580 | 25,597.5 | 0 | 21,960.445 | 19,876 | 52.8 | 300.182 | 5,802.022 | 7,853.473 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 654.824 | -2,986.1 | 14,079.889 | 578.182 | -1,488.433 | -1,633.441 | 2,283.092 | 18.78 | 1,664.699 | 2,745.04 | 2,009.046 | 1,615.762 | 1,360.364 | 781.323 | 1,109.45 | 876.24 | 733.896 | 422.959 | 2,557.734 | 1,417.796 |
| Investing Cash Flow
| -847.206 | 8,078.5 | -4,055.076 | 4,185.916 | -568.433 | -1,433.441 | -1,041.908 | 3,008.025 | 5,008.996 | 1,440.058 | 1,889.774 | -1,096.501 | 992.213 | 867.561 | 6,607.806 | 8,269.165 | 988.579 | -14.16 | 708.42 | -1,518.343 |
| Financing Activities: | ||||||||||||||||||||
| Debt Repayment
| -181.3 | -168.677 | -0.24 | -1.53 | -4.06 | -4.06 | -6.06 | -7.78 | -7.425 | 0 | -4.509 | -3.119 | -2.567 | -2.567 | -2.308 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,073.092 | 0 |
| Dividends Paid
| -5,415.729 | -15,254.999 | -5,066.35 | -6,770.443 | -4,084.559 | -2,964.606 | -2,541.091 | -4,235.15 | -5,293.939 | -3,388.12 | -4,213.79 | -3,781.544 | -3,376.677 | -2,530.273 | -3,366.718 | -3,030.45 | -2,612.888 | -2,358.78 | -2,086.809 | -879.408 |
| Other Financing Activities
| -17.9 | -178.3 | -175.833 | -183.622 | -884.034 | -614.926 | -519.197 | -864.692 | -1,081.953 | -587.778 | -723.08 | -621.685 | -568.845 | -438.614 | -579.36 | -522.926 | -372.008 | -332.486 | -280.453 | -120.34 |
| Financing Cash Flow
| -5,612.729 | -15,433.3 | -5,242.423 | -6,961.393 | -4,276.215 | -3,583.592 | -3,066.348 | -5,107.622 | -6,383.317 | -3,975.898 | -4,941.379 | -4,406.348 | -3,948.089 | -2,971.454 | -3,948.386 | -3,553.376 | -2,984.896 | -2,691.266 | -4,440.354 | -999.748 |
| Other Information: | ||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.07 | 0 | 0 | 0 | 0 | 169.202 |
| Net Change In Cash
| 310.376 | -2,512.5 | -1,190.021 | 3,003.777 | 60.349 | -1,023.252 | 619.71 | 260.367 | 17.586 | 165.306 | -238.463 | -2,366.923 | 400.517 | 2,689.74 | 7,774.516 | 8,016.092 | 1,192.03 | -119.485 | -238.113 | -58.677 |
| Cash At End Of Period
| 860.76 | 349.4 | 2,861.871 | 4,051.892 | 1,048.115 | 987.766 | 2,011.018 | 1,409.229 | 1,173.528 | 165.306 | 1,138.2 | 1,376.663 | 20,430.578 | 20,030.061 | 17,340.321 | 9,565.805 | 1,549.713 | 357.683 | 477.168 | 715.281 |